ALEC - Alector, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
South San Francisco,
United States
Type: Equity
ALEC price evolution
ALEC
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $76.1 | $103.51 | $133.09 | $197.03 |
| Short term investments | $474.31 | $486.9 | $498.51 | $473.77 |
| Net receivables | $10.46 | $7.83 | $4.7 | |
| Inventory | ||||
| Total current assets | $565.81 | $613.15 | $647.99 | $686 |
| Long term investments | ||||
| Property, plant & equipment | $47.06 | $49.15 | $50.59 | $52.06 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $56.02 | $59.25 | $60.74 | $62.34 |
| Total investments | $474.31 | $486.9 | $498.51 | $473.77 |
| Total assets | $621.83 | $672.39 | $708.74 | $748.34 |
| Current liabilities | ||||
| Accounts payable | $11.48 | $4.68 | $4.67 | $3.13 |
| Deferred revenue | $293.82 | $310.41 | $313.89 | $492.85 |
| Short long term debt | $8.46 | $8.39 | $8.2 | $8.13 |
| Total current liabilities | $177.95 | $155.4 | $132.27 | $99.3 |
| Long term debt | $30.46 | $31.84 | $32.74 | $34.05 |
| Total noncurrent liabilities | $309.72 | $354.44 | $380.16 | $466.03 |
| Total debt | $38.92 | $40.23 | $40.94 | $42.18 |
| Total liabilities | $487.67 | $509.84 | $512.43 | $565.33 |
| Shareholders' equity | ||||
| Retained earnings | -$710.08 | -$668.64 | -$624.17 | -$625.54 |
| Other shareholder equity | $0.18 | -$0.72 | -$1.39 | -$2.2 |
| Total shareholder equity | $134.16 | $162.56 | $196.31 | $183.01 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $76.1 | $155.79 | $330.62 | $51.44 |
| Short term investments | $474.31 | $558.53 | $406.1 | $363.34 |
| Net receivables | $2.59 | $7.39 | ||
| Inventory | ||||
| Total current assets | $565.81 | $726.43 | $749.71 | $421.51 |
| Long term investments | ||||
| Property, plant & equipment | $47.06 | $53.33 | $57.9 | $62.65 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $56.02 | $61.21 | $64.94 | $66.74 |
| Total investments | $474.31 | $558.53 | $406.1 | $363.34 |
| Total assets | $621.83 | $787.65 | $814.66 | $488.25 |
| Current liabilities | ||||
| Accounts payable | $11.48 | $4.19 | $4.75 | $3 |
| Deferred revenue | $293.82 | $491.6 | $425.22 | $132.3 |
| Short long term debt | $8.46 | $8.06 | $7.79 | $7.51 |
| Total current liabilities | $177.95 | $93.81 | $139.56 | $68.09 |
| Long term debt | $30.46 | $35.27 | $39.81 | $43.74 |
| Total noncurrent liabilities | $309.72 | $479.4 | $374.38 | $152.63 |
| Total debt | $38.92 | $43.33 | $47.6 | $51.26 |
| Total liabilities | $487.67 | $573.21 | $513.93 | $220.72 |
| Shareholders' equity | ||||
| Retained earnings | -$710.08 | -$579.69 | -$446.38 | -$410.05 |
| Other shareholder equity | $0.18 | -$4.58 | -$0.94 | $0.61 |
| Total shareholder equity | $134.16 | $214.44 | $300.72 | $267.53 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $15.19 | $9.11 | $56.21 | $16.55 |
| Cost of revenue | ||||
| Gross Profit | $15.19 | $9.11 | $56.21 | $16.55 |
| Operating activities | ||||
| Research & development | $47.72 | $46.33 | $46.18 | $51.89 |
| Selling, general & administrative | $14.92 | $13.36 | $13.63 | $14.78 |
| Total operating expenses | $62.64 | $59.69 | $59.8 | $66.66 |
| Operating income | -$47.45 | -$50.58 | -$3.59 | -$50.12 |
| Income from continuing operations | ||||
| EBIT | -$39.77 | -$43.22 | $2.77 | -$44.96 |
| Income tax expense | $1.67 | $1.25 | $1.39 | $0.9 |
| Interest expense | ||||
| Net income | ||||
| Net income | -$41.43 | -$44.48 | $1.38 | -$45.86 |
| Income (for common shares) | -$41.43 | -$44.48 | $1.38 | -$45.86 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $97.06 | $133.62 | $207.09 | $21.1 |
| Cost of revenue | ||||
| Gross Profit | $97.06 | $133.62 | $207.09 | $21.1 |
| Operating activities | ||||
| Research & development | $192.12 | $210.42 | $189.41 | $156.87 |
| Selling, general & administrative | $56.69 | $61.03 | $55.04 | $59.4 |
| Total operating expenses | $248.8 | $271.45 | $244.44 | $216.27 |
| Operating income | -$151.74 | -$137.83 | -$37.36 | -$195.17 |
| Income from continuing operations | ||||
| EBIT | -$125.18 | -$130.06 | -$36.33 | -$190.23 |
| Income tax expense | $5.21 | $3.25 | ||
| Interest expense | ||||
| Net income | ||||
| Net income | -$130.39 | -$133.31 | -$36.33 | -$190.23 |
| Income (for common shares) | -$130.39 | -$133.31 | -$36.33 | -$190.23 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$41.43 | -$44.48 | $1.38 | -$45.86 |
| Operating activities | ||||
| Depreciation | $2.26 | $2.26 | $2.23 | $2.1 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $11.54 | $10.06 | $10.22 | $10.97 |
| Total cash flows from operations | -$46.07 | -$46.54 | -$43 | -$48.55 |
| Investing activities | ||||
| Capital expenditures | -$0.23 | $0.09 | -$1.22 | -$1.02 |
| Investments | $18.3 | $16.87 | -$20.6 | $89.73 |
| Total cash flows from investing | $18.07 | $16.96 | -$21.82 | $88.7 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.47 | -$0.88 | $0.88 | $1.08 |
| Net borrowings | ||||
| Total cash flows from financing | $0.59 | $0.88 | $1.08 | |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$27.41 | -$29.58 | -$63.94 | $41.23 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$130.39 | -$133.31 | -$36.33 | -$190.23 |
| Operating activities | ||||
| Depreciation | $8.85 | $8.47 | $8.31 | $7.26 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $42.8 | $46.15 | $40.78 | $30.52 |
| Total cash flows from operations | -$184.16 | -$20.33 | $298.55 | -$166.73 |
| Investing activities | ||||
| Capital expenditures | -$2.38 | -$4.12 | -$3.25 | -$5.03 |
| Investments | $104.3 | -$154.9 | -$46.42 | -$100.02 |
| Total cash flows from investing | $101.92 | -$159.01 | -$49.66 | -$105.05 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.55 | $4.51 | $30.3 | $232.11 |
| Net borrowings | ||||
| Total cash flows from financing | $2.55 | $4.51 | $30.3 | $232.11 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$79.69 | -$174.83 | $279.18 | -$39.67 |
News
Fundamentals
| Market cap | $408.27M |
|---|---|
| Enterprise value | $371.09M |
| Shares outstanding | 84.88M |
| Revenue | $97.06M |
|---|---|
| EBITDA | -$116.33M |
| EBIT | -$125.18M |
| Net Income | -$130.39M |
| Revenue Q/Q | 5.19% |
| Revenue Y/Y | -27.36% |
| P/E ratio | -3.13 |
|---|---|
| EV/Sales | 3.82 |
| EV/EBITDA | -3.19 |
| EV/EBIT | -2.96 |
| P/S ratio | 4.21 |
| P/B ratio | 3.05 |
| Book/Share | 1.58 |
| Cash/Share | 0.90 |
| EPS | -$1.54 |
|---|---|
| ROA | -18.96% |
| ROE | -77.15% |
| Debt/Equity | 3.64 |
|---|---|
| Net debt/EBITDA | -3.54 |
| Current ratio | 3.18 |
| Quick ratio | 3.18 |